MeSH term
Frequency | Condition_Probility | Aged | 16 | 0.0 |
Aged, 80 and over | 8 | 0.0 |
Female | 50 | 0.0 |
Humans | 211 | 0.0 |
Alkaline Phosphatase/metabolism | 2 | 1.0 |
Animals | 132 | 0.0 |
Cell Movement | 4 | 0.0 |
Chondrocytes/*metabolism | 2 | 6.0 |
DNA, Complementary/metabolism | 4 | 0.0 |
*Gene Expression Regulation, Developmental | 3 | 0.0 |
Immunohistochemistry | 19 | 0.0 |
Microscopy, Fluorescence | 3 | 0.0 |
Mutation | 6 | 0.0 |
Research Support, Non-U.S. Gov't | 141 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 14 | 0.0 |
Sialoglycoproteins/metabolism | 2 | 4.0 |
Signal Transduction | 19 | 0.0 |
Time Factors | 15 | 0.0 |
Transfection | 25 | 0.0 |
Cell Line | 32 | 0.0 |
Disease Progression | 5 | 0.0 |
Down-Regulation | 3 | 0.0 |
Male | 46 | 0.0 |
Prostatic Neoplasms/*metabolism/*pathology | 2 | 11.0 |
*Protein-Tyrosine Kinase | 6 | 1.0 |
RNA, Messenger/metabolism | 12 | 0.0 |
Receptors, Fibroblast Growth Factor/genetics/*metabolism | 4 | 11.0 |
Reference Values | 6 | 0.0 |
Mice | 73 | 0.0 |
Mice, Inbred C3H | 4 | 0.0 |
Mice, Nude | 11 | 0.0 |
Neoplasm Transplantation | 5 | 0.0 |
*Neovascularization, Pathologic | 3 | 0.0 |
RNA, Messenger/genetics/metabolism | 5 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 77 | 0.0 |
Tumor Cells, Cultured | 40 | 0.0 |
Vascular Endothelial Growth Factor A | 11 | 0.0 |
Vascular Endothelial Growth Factors | 11 | 0.0 |
Binding Sites | 9 | 0.0 |
Carbohydrate Sequence | 4 | 1.0 |
Fibroblast Growth Factor 2/*metabolism | 8 | 14.0 |
Protein Binding | 13 | 0.0 |
Blotting, Western | 14 | 0.0 |
Cattle | 16 | 0.0 |
Cell Culture Techniques | 4 | 0.0 |
Cell Differentiation | 16 | 0.0 |
Fluorescent Antibody Technique, Indirect | 2 | 0.0 |
Microscopy, Confocal | 3 | 0.0 |
Polymerase Chain Reaction | 13 | 0.0 |
Rabbits | 4 | 0.0 |
Rats | 30 | 0.0 |
Adolescent | 7 | 0.0 |
Cells, Cultured | 44 | 0.0 |
*Mutation | 2 | 0.0 |
Osteoblasts/*pathology | 2 | 50.0 |
RNA, Messenger/*genetics | 2 | 0.0 |
Receptor Protein-Tyrosine Kinases/*genetics | 3 | 0.0 |
Receptors, Fibroblast Growth Factor/*genetics | 8 | 3.0 |
Transcription Factors/*genetics | 2 | 0.0 |
Cell Adhesion | 2 | 0.0 |
Cell Division | 20 | 0.0 |
Dose-Response Relationship, Drug | 17 | 0.0 |
Endothelium, Vascular/*cytology | 2 | 1.0 |
Enzyme Inhibitors/pharmacology | 5 | 0.0 |
Flavonoids/pharmacology | 2 | 0.0 |
Genes, Dominant | 3 | 0.0 |
Microscopy, Electron, Scanning | 2 | 0.0 |
Phosphorylation | 8 | 0.0 |
Plasmids/metabolism | 2 | 0.0 |
Recombinant Proteins/metabolism | 6 | 0.0 |
Amino Acid Motifs | 2 | 0.0 |
Amino Acid Sequence | 17 | 0.0 |
COS Cells | 6 | 0.0 |
*Genetic Vectors | 5 | 1.0 |
Kinetics | 9 | 0.0 |
Ligands | 9 | 0.0 |
Molecular Sequence Data | 28 | 0.0 |
Peptide Library | 2 | 1.0 |
Receptors, Fibroblast Growth Factor/*metabolism | 4 | 7.0 |
Transgenes | 5 | 1.0 |
Adult | 16 | 0.0 |
Antiviral Agents/pharmacology | 2 | 3.0 |
Ganciclovir/pharmacology | 2 | 6.0 |
*Gene Transfer Techniques | 5 | 1.0 |
Genes, Reporter | 5 | 0.0 |
Luciferases/metabolism | 3 | 0.0 |
Middle Aged | 17 | 0.0 |
DNA-Binding Proteins/genetics | 2 | 0.0 |
Exons/genetics | 2 | 0.0 |
Fibroblast Growth Factor 2/genetics | 5 | 15.0 |
Fibroblast Growth Factors/*genetics | 4 | 8.0 |
In Situ Hybridization | 10 | 0.0 |
Mesoderm/metabolism | 2 | 2.0 |
Signal Transduction/genetics | 3 | 1.0 |
Trans-Activators/genetics | 2 | 0.0 |
Transforming Growth Factor beta/*genetics | 2 | 2.0 |
Up-Regulation/genetics | 2 | 2.0 |
Fibroblast Growth Factor 2/metabolism/pharmacology | 3 | 42.0 |
Isoenzymes/metabolism | 2 | 0.0 |
Neovascularization, Physiologic/drug effects/*physiology | 4 | 9.0 |
Phosphorylation/drug effects | 4 | 0.0 |
Protein Binding/genetics | 2 | 0.0 |
Protein Kinase C/metabolism | 3 | 0.0 |
Cell Division/drug effects | 28 | 0.0 |
Fibroblast Growth Factor 1/*pharmacology | 3 | 15.0 |
Fibroblast Growth Factor 2/*pharmacology | 20 | 17.0 |
Fibroblast Growth Factors/*pharmacology | 2 | 4.0 |
Pregnancy | 4 | 0.0 |
Rats, Wistar | 3 | 0.0 |
Collagen/metabolism | 3 | 1.0 |
Fibroblast Growth Factor 2/*genetics | 6 | 30.0 |
Flow Cytometry | 4 | 0.0 |
Gene Targeting | 3 | 0.0 |
Genetic Vectors | 4 | 0.0 |
Proto-Oncogene Proteins/*genetics | 2 | 0.0 |
Rats, Sprague-Dawley | 5 | 0.0 |
Cell Division/drug effects/physiology | 4 | 1.0 |
Fibroblast Growth Factor 2/*metabolism/pharmacology | 5 | 41.0 |
Receptors, Fibroblast Growth Factor/drug effects/metabolism | 2 | 50.0 |
Signal Transduction/drug effects/physiology | 3 | 1.0 |
Transcription Factors/*metabolism | 3 | 0.0 |
Cell Separation | 3 | 0.0 |
Fibroblast Growth Factor 2/metabolism | 6 | 6.0 |
Immunoblotting | 3 | 0.0 |
Precipitin Tests | 5 | 0.0 |
Recombinant Fusion Proteins/metabolism | 5 | 0.0 |
Cell Line, Tumor | 3 | 0.0 |
Fibroblast Growth Factor 2/*physiology | 5 | 23.0 |
*Gene Expression Profiling | 2 | 0.0 |
Oligonucleotide Array Sequence Analysis | 3 | 0.0 |
Receptors, Fibroblast Growth Factor/physiology | 4 | 44.0 |
Gene Therapy/*methods | 3 | 0.0 |
Treatment Outcome | 3 | 0.0 |
Cell Differentiation/physiology | 8 | 1.0 |
Neuronal Plasticity/*physiology | 2 | 4.0 |
Craniosynostoses/genetics | 2 | 22.0 |
*Gene Expression | 4 | 0.0 |
Gestational Age | 2 | 0.0 |
Osteogenesis/genetics | 3 | 23.0 |
*Phenotype | 3 | 1.0 |
RNA, Messenger/analysis | 6 | 0.0 |
Skull/*embryology | 3 | 37.0 |
Endothelium, Vascular/cytology/*physiology | 3 | 4.0 |
Fibroblast Growth Factor 2/pharmacology | 16 | 7.0 |
Neovascularization, Physiologic/*drug effects | 4 | 4.0 |
Umbilical Veins | 2 | 0.0 |
Comparative Study | 22 | 0.0 |
Genetic Markers | 2 | 0.0 |
Alternative Splicing | 2 | 0.0 |
Base Sequence | 20 | 0.0 |
CHO Cells | 5 | 0.0 |
Cell Membrane/metabolism | 2 | 0.0 |
Cloning, Molecular | 3 | 0.0 |
Exons | 4 | 0.0 |
Glycosylation | 2 | 0.0 |
Hamsters | 6 | 0.0 |
Heparin/metabolism | 4 | 3.0 |
Models, Biological | 7 | 0.0 |
Protein Isoforms | 4 | 0.0 |
Protein Structure, Tertiary | 5 | 0.0 |
RNA/metabolism | 2 | 0.0 |
Cell Differentiation/*physiology | 2 | 0.0 |
Chondrocytes/*cytology | 2 | 12.0 |
Epidermal Growth Factor/physiology | 2 | 2.0 |
Fibroblast Growth Factor 2/physiology | 5 | 20.0 |
Growth Substances/*physiology | 2 | 1.0 |
Mice, Knockout | 7 | 0.0 |
Neovascularization, Pathologic/*metabolism | 3 | 2.0 |
Organ Culture Techniques | 6 | 1.0 |
Platelet-Derived Growth Factor/metabolism | 2 | 3.0 |
Transforming Growth Factor beta/metabolism | 2 | 1.0 |
Heparin/pharmacology | 5 | 2.0 |
Mice, Inbred C57BL | 12 | 0.0 |
Fibroblast Growth Factors/*metabolism | 7 | 17.0 |
Nitriles/pharmacology | 2 | 1.0 |
Transcription Factors/metabolism | 2 | 0.0 |
Transcription, Genetic | 7 | 0.0 |
Fibroblast Growth Factor 2/genetics/*metabolism | 4 | 28.0 |
Mice, Transgenic | 6 | 0.0 |
Phenotype | 10 | 0.0 |
*Signal Transduction | 12 | 0.0 |
3T3 Cells | 4 | 0.0 |
Heparin/*chemistry | 2 | 20.0 |
Models, Molecular | 4 | 0.0 |
Protein Structure, Secondary | 2 | 0.0 |
Receptors, Fibroblast Growth Factor/*chemistry | 2 | 100.0 |
Fibroblast Growth Factor 2/*biosynthesis | 2 | 9.0 |
Fibroblast Growth Factors/*biosynthesis | 2 | 28.0 |
In Vitro | 6 | 0.0 |
Prostatic Hyperplasia/*metabolism | 2 | 4.0 |
RNA, Messenger/biosynthesis | 3 | 0.0 |
Apoptosis/drug effects | 2 | 0.0 |
Gene Expression Regulation/*drug effects | 3 | 0.0 |
Chick Embryo | 13 | 2.0 |
Endothelium, Vascular/cytology/*drug effects | 3 | 4.0 |
Fibroblast Growth Factor 2/*antagonists & inhibitors | 3 | 60.0 |
Epithelium/pathology | 2 | 1.0 |
Paracrine Communication/*physiology | 2 | 11.0 |
Prostatic Hyperplasia/*metabolism/pathology | 2 | 6.0 |
Mice, SCID | 4 | 0.0 |
Neovascularization, Physiologic/drug effects | 2 | 2.0 |
Allantois/blood supply | 3 | 21.0 |
Chorion/blood supply | 3 | 21.0 |
Mice, Inbred BALB C | 7 | 0.0 |
Recombinant Proteins/pharmacology | 6 | 0.0 |
Child | 4 | 0.0 |
Child, Preschool | 3 | 0.0 |
Fibroblast Growth Factors/*physiology | 3 | 15.0 |
Infant | 3 | 0.0 |
Infant, Newborn | 2 | 0.0 |
Receptor Protein-Tyrosine Kinases/physiology | 3 | 6.0 |
Receptors, Fibroblast Growth Factor/*physiology | 3 | 33.0 |
Signal Transduction/*physiology | 5 | 0.0 |
Crystallography, X-Ray | 4 | 0.0 |
Hydrogen Bonding | 2 | 1.0 |
Mutagenesis, Site-Directed | 5 | 0.0 |
*Point Mutation | 2 | 0.0 |
Protein Conformation | 3 | 0.0 |
Sequence Alignment | 3 | 0.0 |
Sequence Homology, Amino Acid | 6 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 14 | 0.0 |
Signal Transduction/physiology | 3 | 0.0 |
Breast Neoplasms/*metabolism | 2 | 0.0 |
Cell Line, Transformed | 5 | 0.0 |
Cell Nucleus/metabolism | 5 | 0.0 |
Tissue Distribution | 5 | 0.0 |
Cell Survival/drug effects | 3 | 0.0 |
Dimerization | 3 | 0.0 |
Neovascularization, Physiologic | 2 | 1.0 |
Receptors, Fibroblast Growth Factor/metabolism | 8 | 17.0 |
Molecular Mimicry | 2 | 2.0 |
Neovascularization, Pathologic/*drug therapy | 2 | 4.0 |
Xenograft Model Antitumor Assays | 2 | 0.0 |
Cell Differentiation/genetics | 2 | 0.0 |
Craniosynostoses/*genetics | 2 | 5.0 |
Receptor Protein-Tyrosine Kinases/genetics | 3 | 2.0 |
Biological Markers/analysis | 2 | 0.0 |
Cell Culture Techniques/methods | 3 | 1.0 |
Culture Media, Serum-Free | 4 | 1.0 |
Immunohistochemistry/methods | 2 | 0.0 |
Models, Animal | 2 | 0.0 |
Cell Differentiation/drug effects | 9 | 0.0 |
Protein Structure, Quaternary | 2 | 1.0 |
DNA, Complementary/genetics | 2 | 0.0 |
Fibroblast Growth Factor 2/*biosynthesis/genetics | 2 | 28.0 |
Gene Expression/drug effects | 2 | 0.0 |
Promoter Regions (Genetics) | 5 | 0.0 |
DNA Primers | 6 | 0.0 |
Gene Expression Regulation/drug effects | 2 | 0.0 |
Parathyroid Hormone-Related Protein | 2 | 2.0 |
Proteins/genetics/*metabolism | 2 | 0.0 |
Signal Transduction/*genetics | 2 | 1.0 |
DNA/metabolism | 2 | 0.0 |
Mitogen-Activated Protein Kinase 3 | 3 | 0.0 |
Signal Transduction/*drug effects | 4 | 1.0 |
Adenoviridae/*genetics | 5 | 2.0 |
Gene Expression Regulation | 3 | 0.0 |
Receptors, Fibroblast Growth Factor/*biosynthesis/genetics | 3 | 27.0 |
Carbohydrate Conformation | 2 | 1.0 |
Cell Movement/drug effects | 2 | 0.0 |
Microscopy, Electron | 2 | 0.0 |
*Gene Expression Regulation, Neoplastic | 2 | 0.0 |
Receptor Protein-Tyrosine Kinases/genetics/metabolism | 3 | 5.0 |
Receptors, Fibroblast Growth Factor/genetics/metabolism | 3 | 13.0 |
Embryo | 3 | 0.0 |
*Alternative Splicing | 2 | 0.0 |
Receptors, Vascular Endothelial Growth Factor | 2 | 0.0 |
Fibroblast Growth Factors/*analysis | 2 | 25.0 |
Lung Neoplasms/secondary | 2 | 2.0 |
Staining and Labeling | 2 | 0.0 |
Tumor Markers, Biological/metabolism | 2 | 0.0 |
Mitogen-Activated Protein Kinase Kinases/metabolism | 3 | 1.0 |
Culture Techniques | 2 | 0.0 |
Platelet-Derived Growth Factor/analysis | 2 | 8.0 |
Recombinant Proteins | 2 | 0.0 |
Wound Healing | 2 | 1.0 |
Epidermal Growth Factor/*pharmacology | 2 | 0.0 |
Glial Fibrillary Acidic Protein/metabolism | 2 | 0.0 |
Fibroblast Growth Factor 2/genetics/metabolism/*physiology | 3 | 100.0 |
Gene Expression | 12 | 0.0 |
Enzyme-Linked Immunosorbent Assay | 7 | 0.0 |
Fibroblasts/metabolism | 2 | 0.0 |
Blotting, Southern | 3 | 0.0 |
Mice, Mutant Strains | 2 | 0.0 |
*Neoplasm Proteins | 3 | 0.0 |
Receptor Protein-Tyrosine Kinases/*genetics/metabolism | 4 | 6.0 |
Receptors, Fibroblast Growth Factor/*genetics/metabolism | 4 | 18.0 |
Transcription Factors/genetics/*metabolism | 2 | 0.0 |
*Adaptor Proteins, Signal Transducing | 2 | 0.0 |
Blotting, Northern | 8 | 0.0 |
Endothelial Growth Factors/metabolism | 2 | 1.0 |
Fibroblast Growth Factor 2/*genetics/*metabolism | 2 | 50.0 |
Lymphokines/metabolism | 2 | 0.0 |
Up-Regulation | 8 | 0.0 |
*Transcription Factors | 2 | 0.0 |
Chromosome Mapping | 2 | 0.0 |
Growth Substances/pharmacology | 2 | 1.0 |
Receptors, Fibroblast Growth Factor/biosynthesis/*genetics | 2 | 18.0 |
Acrocephalosyndactylia/genetics | 2 | 15.0 |
Fibroblast Growth Factor 1 | 5 | 17.0 |
Point Mutation | 4 | 0.0 |
Endothelium, Vascular/drug effects | 2 | 3.0 |
Protein Binding/drug effects | 2 | 0.0 |
Cell Lineage | 3 | 0.0 |
Extracellular Matrix/chemistry/metabolism | 2 | 18.0 |
Stem Cells/*cytology | 2 | 2.0 |
Prostate/*metabolism | 2 | 2.0 |
Morphogenesis | 2 | 0.0 |
Gene Expression Regulation, Developmental | 3 | 0.0 |
*Repressor Proteins | 2 | 0.0 |
Transcription Factors/genetics | 3 | 0.0 |
*Transforming Growth Factor beta | 2 | 1.0 |
Mitogen-Activated Protein Kinases/metabolism | 4 | 0.0 |
Proto-Oncogene Proteins c-fos/metabolism | 2 | 1.0 |
Hela Cells | 2 | 0.0 |
PC12 Cells | 4 | 1.0 |
Ciliary Neurotrophic Factor/pharmacology | 2 | 20.0 |
Disease Models, Animal | 3 | 0.0 |
Growth Substances/*pharmacology | 3 | 0.0 |
Genotype | 3 | 0.0 |
Species Specificity | 3 | 0.0 |
Binding, Competitive | 3 | 0.0 |
Chromatography, Affinity | 3 | 0.0 |
Radioligand Assay | 2 | 0.0 |
Swine | 2 | 0.0 |
Fibroblast Growth Factor 2/metabolism/*pharmacology | 2 | 50.0 |
*Neovascularization, Physiologic | 3 | 1.0 |
Chimeric Proteins/metabolism | 2 | 1.0 |
Fibroblast Growth Factors/metabolism | 4 | 7.0 |
Receptors, Fibroblast Growth Factor/*genetics/*metabolism | 4 | 23.0 |
Substrate Specificity | 2 | 0.0 |
Cell Division/physiology | 6 | 0.0 |
Receptor Protein-Tyrosine Kinases/genetics/*physiology | 2 | 7.0 |
Receptors, Fibroblast Growth Factor/genetics/*physiology | 2 | 22.0 |
Liver Neoplasms/*metabolism/pathology | 2 | 2.0 |
Transforming Growth Factor beta/pharmacology | 3 | 0.0 |
Tumor Necrosis Factor-alpha/pharmacology | 2 | 0.0 |
Methionine/*analogs & derivatives/pharmacology | 2 | 50.0 |
Radiation Tolerance/*drug effects | 2 | 11.0 |
*Fibroblast Growth Factors | 6 | 6.0 |
Biological Markers | 3 | 0.0 |
Culture Media | 4 | 0.0 |
Fetus | 2 | 0.0 |
Neurons/*cytology/drug effects | 2 | 25.0 |
Stem Cells/*cytology/drug effects/physiology | 2 | 40.0 |
Coculture Techniques | 4 | 0.0 |
Stress, Mechanical | 4 | 1.0 |
*Adenoviridae | 2 | 6.0 |
Growth Substances/*biosynthesis | 2 | 4.0 |
Fibroblast Growth Factor 2/*secretion | 2 | 50.0 |
Prostatic Hyperplasia/metabolism | 2 | 6.0 |
Macromolecular Substances | 2 | 0.0 |
Immunoenzyme Techniques | 5 | 0.0 |
2-Aminopurine/pharmacology | 2 | 16.0 |
Allantois/blood supply/drug effects | 2 | 33.0 |
Aorta/cytology | 2 | 2.0 |
Chorion/blood supply/drug effects | 2 | 25.0 |
Depression, Chemical | 2 | 1.0 |
Mitogen-Activated Protein Kinase 1 | 2 | 1.0 |
Protein Processing, Post-Translational/drug effects | 2 | 1.0 |
Fibroblast Growth Factor 2/*analysis/genetics | 2 | 66.0 |
Receptors, Fibroblast Growth Factor/*analysis/genetics | 3 | 75.0 |
Gelatinase A | 2 | 2.0 |
Protein-Tyrosine Kinase/metabolism | 3 | 0.0 |
*Proto-Oncogene Proteins | 2 | 0.0 |
Molecular Weight | 2 | 0.0 |
Fibroblast Growth Factors/genetics/*metabolism | 2 | 14.0 |
Prostatic Neoplasms/*metabolism/pathology | 2 | 2.0 |
Mitogens/pharmacology | 2 | 0.0 |
Growth Substances/*metabolism | 2 | 1.0 |
Electrophoresis, Polyacrylamide Gel | 2 | 0.0 |
*Gene Therapy | 4 | 1.0 |
Clone Cells | 2 | 0.0 |
Epithelial Cells | 3 | 0.0 |
Stem Cells | 2 | 1.0 |
Rats, Inbred F344 | 2 | 0.0 |
Receptor, Epidermal Growth Factor/metabolism | 2 | 0.0 |
Sequence Homology, Nucleic Acid | 2 | 0.0 |
Mitogens/metabolism | 3 | 12.0 |
Calcium/*metabolism | 2 | 0.0 |
Receptors, Fibroblast Growth Factor/*biosynthesis | 2 | 28.0 |
Xenopus | 2 | 0.0 |
DNA Primers/chemistry | 2 | 0.0 |
Recombinant Proteins/genetics/metabolism | 3 | 0.0 |
Radiation-Protective Agents/*pharmacology | 2 | 10.0 |
DNA Primers/genetics | 3 | 0.0 |
DNA-Binding Proteins/*genetics | 2 | 0.0 |
Proto-Oncogenes/*genetics | 2 | 2.0 |
Cross-Linking Reagents | 2 | 0.0 |
Neurites/physiology | 2 | 10.0 |
Enzyme Activation | 4 | 0.0 |
Fibroblast Growth Factor 2/biosynthesis/genetics/*physiology | 3 | 75.0 |
Neovascularization, Physiologic/*drug effects/physiology | 2 | 11.0 |
Heart/physiopathology | 2 | 5.0 |
Transforming Growth Factor beta/*physiology | 2 | 1.0 |
Cattle/*genetics | 2 | 1.0 |
Chromosomes, Human, Pair 4/*genetics | 2 | 2.0 |
Breast/*cytology | 3 | 8.0 |
Culture Media, Conditioned/pharmacology | 2 | 1.0 |
Umbilical Veins/cytology | 2 | 0.0 |
Gene Expression Regulation, Developmental/drug effects | 2 | 7.0 |
DNA, Complementary | 2 | 0.0 |
Epithelium/metabolism | 4 | 1.0 |
MAP Kinase Kinase 1 | 2 | 1.0 |
MAP Kinase Kinase 2 | 2 | 4.0 |
*Mitogen-Activated Protein Kinases | 2 | 0.0 |
Osteoblasts/drug effects/metabolism | 2 | 20.0 |
Models, Chemical | 2 | 0.0 |
Surface Plasmon Resonance | 3 | 1.0 |
Bone Marrow Cells | 2 | 0.0 |
Receptors, Fibroblast Growth Factor/analysis | 3 | 18.0 |
Gene Expression Regulation, Neoplastic | 4 | 0.0 |
Fibroblasts | 2 | 0.0 |
Gene Silencing | 2 | 0.0 |
Biopsy | 2 | 0.0 |
Fibroblast Growth Factor 1/*biosynthesis | 2 | 100.0 |
*N-Glycosyl Hydrolases | 2 | 3.0 |
Cell Differentiation/genetics/physiology | 2 | 6.0 |
Transcription Factors/*genetics/metabolism | 2 | 0.0 |
Fibroblast Growth Factor 2/biosynthesis | 2 | 7.0 |
Neurons/*metabolism | 2 | 0.0 |
Cricetulus | 2 | 0.0 |
Recombinant Fusion Proteins/pharmacology | 2 | 2.0 |
Forskolin/pharmacology | 2 | 0.0 |
Chromatography | 2 | 1.0 |
Case-Control Studies | 2 | 0.0 |
Proteins/*physiology | 2 | 1.0 |
Lymphokines/pharmacology | 2 | 1.0 |
Fibroblast Growth Factor 1/metabolism | 2 | 28.0 |
Phosphotyrosine/metabolism | 2 | 0.0 |
Sequence Deletion | 2 | 0.0 |
Protein-Serine-Threonine Kinases/metabolism | 2 | 0.0 |
Tyrosine/metabolism | 2 | 0.0 |
Proto-Oncogene Proteins/metabolism | 2 | 0.0 |
Nuclear Proteins/*metabolism | 2 | 0.0 |
